VRAYLAR
(cariprazine)
Cost & Savings

The amount you pay for VRAYLAR can depend on a number of factors, including your access to prescription drug coverage, the type of insurance you have, and even the level of coverage your insurance may provide.

This page provides information that can help you determine how much VRAYLAR may cost, as well as financial support programs that may be able to help you afford your medication.

On this page

VRAYLAR ® (cariprazine) List Price

The list price, also known as the wholesale acquisition cost (WAC), for a 30-day supply of VRAYLAR is $1,446.55 as of January 2024. However, the amount you will pay will largely depend on your health insurance coverage.

Call 1-800-678-1605 to find out how much VRAYLAR will cost for you.

You may be able to pay less for VRAYLAR with VRAYPAY SM

Join our savings program, VRAYPAY SM , and you may be able to decrease your out-of-pocket costs. Depending on your insurance coverage, new eligible commercially insured patients may pay as little as $0 for their first two 30-day fills and as little as $5 for 30- or 90-day refills of VRAYLAR or may pay as little as $0 per 30-day supply for each of up to twelve (12) prescription fills or as little as $0 per 90-day supply for each of up to four (4) prescription fills of a generic antidepressant up to $200 per fill.*

Get your savings card and talk to your doctor about a 90-day prescription to save more time and money at the pharmacy.

*Terms and conditions apply. Available to commercially insured patients only. See Terms and Conditions for full details.

Not Actual Card Image

Insurance Information †

Commercial insurance (usually provided by an employer)

As little as $0 a month for the first two refills and as little as $5 for 30-day or 90-day refills with a VRAYLAR ® Savings Card.
Learn about the card

Most patients pay $4 or less, depending on state plan.

Contact your prescription coverage provider to learn more.

Out-of-pocket costs vary from state to state. Refer to your state agency for details about Medicaid out-of-pocket costs, or visit Medicaid.gov.

Medicare Part D

Reasons why your monthly cost may differ:

• A lack of supplemental coverage (Part D)
• The benefit varies during different coverage phases of most Part D plans
• Not all Part D plans are the same and they may have different rules and benefits

Contact your prescription coverage provider to learn more.

Medicare Low Income Subsidy (LIS)

Depending on your eligibility, $11.20 or less for a 30-day supply.

Uninsured or if you cannot afford your medication

The AbbVie ® Patient Assistance Program provides certain products to patients in the United States who are unable to afford the cost of their medicine and who meet other eligibility requirements.

† Important details about understanding your individual costs: The chart above provides cost information based on what a person with the type of coverage listed may pay for. Your type of health or prescription insurance plan will determine exactly how much you will pay. Information listed is accurate as of January 2024 and is based on publicly available benefit design information for Medicaid and Medicare Part D out-of-pocket costs for 2024 plan year.

Insurance Coverage Support

To help you understand your coverage and what your out-of-pocket costs may be, it’s important to verify your benefits.

And even if your VRAYLAR isn’t covered, there may be ways to save on your prescription. An Insurance Specialist can talk you through your coverage and help identify potential savings options—regardless of your insurance coverage.

For insurance questions or to verify your benefits, call 1-800-678-1605 (select option 4).

myAbbVie Assist

If you are having difficulty paying for your medicine, myAbbVie Assist may be able to help.

myAbbVie Assist, our patient assistance program, provides AbbVie medicine to qualifying patients. It is intended for people that live in the United States, have limited or no health insurance coverage, and demonstrate qualifying financial need.

INDICATIONS AND USAGE

VRAYLAR is a prescription medicine used in adults:

• along with antidepressant medicines to treat major depressive disorder (MDD)
• for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder
• to treat depressive episodes that happen with bipolar I (bipolar depression)

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about VRAYLAR?

Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis.

VRAYLAR and antidepressants may increase suicidal thoughts or actions in some children and young adults especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor.

VRAYLAR may cause serious side effects, including:

• Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death
• Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These can be symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS.
• Uncontrolled body movements (tardive dyskinesia or TD): VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR.
• Late-occurring side effects: VRAYLAR stays in your body for a long time. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases. Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR.
• Problems with your metabolism, such as:
  • High blood sugar and diabetes: Increases in blood sugar can happen in some people who take VRAYLAR. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Tell your healthcare provider if you have symptoms such as feeling very thirsty, very hungry, or sick to your stomach, urinating more than usual, feeling weak, tired, confused, or your breath smells fruity.
  • Increased fat levels (cholesterol and triglycerides) in your blood: Your healthcare provider should check fat levels in your blood before or soon after starting VRAYLAR and during treatment.
  • Weight gain: Weight gain has been reported with VRAYLAR. You and your healthcare provider should check your weight before and regularly during treatment.

  Who should not take VRAYLAR?

  Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).

  What should I tell my healthcare provider before taking VRAYLAR?

  Tell your healthcare provider about any medical conditions and if you:

  • have or have had heart problems or a stroke
  • have or have had low or high blood pressure
  • have or have had diabetes or high blood sugar in you or your family
  • have or have had high levels of total cholesterol, LDL-cholesterol, or triglycerides; or low levels of HDL-cholesterol
  • have or have had seizures (convulsions)
  • have or have had kidney or liver problems
  • have or have had low white blood cell count
  • are pregnant or plan to become pregnant. VRAYLAR may harm your unborn baby. Taking VRAYLAR during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms after birth. Talk to your healthcare provider about the risk to your unborn baby if you take VRAYLAR during pregnancy. If you become pregnant or think you are pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/.
  • are breastfeeding or plan to breastfeed. It is not known if VRAYLAR passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with VRAYLAR.

  Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider.

  What are the most common side effects of VRAYLAR?

  The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness.

  These are not all the possible side effects of VRAYLAR.

  INDICATIONS AND USAGE

  VRAYLAR is a prescription medicine used in adults:

  • along with antidepressant medicines to treat major depressive disorder (MDD)
  • for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder
  • to treat depressive episodes that happen with bipolar I (bipolar depression)

  Please see the full Prescribing Information, including Boxed Warnings, and Medication Guide.
  

  You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

  If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.